Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06826339 · ClinicalTrials.gov registry record · Phase 4
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
A Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Tiger Biosciences.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 340
- Enrollment target
- 1
- Study location
NCT06826339 is a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by Tiger Biosciences. The registered enrollment target is 340 participants, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06826339, a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by Tiger Biosciences.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER ACApatch™
- OTHER caregraFT™
Study Locations (1)
Pennsylvania
- Serena Group - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2027-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06826339
The ClinicalTrials.gov registry entry for NCT06826339 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (36% higher). The listed sponsor is Tiger Biosciences, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT06826339 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06826339 about?
NCT06826339 is a clinical study titled "Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.". Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
What is the current status of trial NCT06826339?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 340 participants. The study started on 2024-12-06. Estimated completion is 2027-12.
What conditions does trial NCT06826339 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Diabetic Foot, Ulcer, Ulcer Foot.
What interventions are being tested in trial NCT06826339?
The interventions under investigation include: Standard of Care (OTHER), ACApatch™ (OTHER), caregraFT™ (OTHER).
Who is sponsoring clinical trial NCT06826339?
This trial is sponsored by Tiger Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06826339 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
ACTIVE NOT RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.